{"entity":{"type":"insider","cik":"0001619834","url":"/insider/0001619834","json_url":"/insider/0001619834.json","name":"Burke Steven Keith","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":17,"first":"2017-12-18","last":"2026-02-04","span_basis":"filed_date"},"name_variants":[{"name":"Burke Steven Keith","source":"filing","n_filings":17,"first_seen":"2017-12-18","last_seen":"2026-02-04"}],"transactions":[{"id":5835184,"accession":"0001619834-26-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001619834-26-000002","line_url":"/filing/0001619834-26-000002#line-3","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25375.0,"shares_display":"25,375","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":35271.25,"total_display":"35,271.25","shares_owned_after":969133.0,"shares_owned_after_display":"969,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":5835182,"accession":"0001619834-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001619834-26-000002","line_url":"/filing/0001619834-26-000002#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21582.0,"shares_display":"21,582","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":29998.98,"total_display":"29,998.98","shares_owned_after":994508.0,"shares_owned_after_display":"994,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":5835179,"accession":"0001619834-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001619834-26-000002","line_url":"/filing/0001619834-26-000002#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20701.0,"shares_display":"20,701","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":28774.39,"total_display":"28,774.39","shares_owned_after":948432.0,"shares_owned_after_display":"948,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":4220096,"accession":"0001562180-25-001997","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-001997","line_url":"/filing/0001562180-25-001997#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7144.0,"shares_display":"7,144","price_per_share":1.83,"price_display":"1.83","price_state":"stated","total_value":13073.52,"total_display":"13,073.52","shares_owned_after":809090.0,"shares_owned_after_display":"809,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":4650148,"accession":"0001562180-25-000916","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-25-000916","line_url":"/filing/0001562180-25-000916#line-3","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27236.0,"shares_display":"27,236","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":57195.6,"total_display":"57,195.60","shares_owned_after":816234.0,"shares_owned_after_display":"816,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":4650143,"accession":"0001562180-25-000916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-000916","line_url":"/filing/0001562180-25-000916#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23270.0,"shares_display":"23,270","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":48867.0,"total_display":"48,867.00","shares_owned_after":843470.0,"shares_owned_after_display":"843,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":3207432,"accession":"0001562180-24-002020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-002020","line_url":"/filing/0001562180-24-002020#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7169.0,"shares_display":"7,169","price_per_share":1.58,"price_display":"1.58","price_state":"stated","total_value":11327.02,"total_display":"11,327.02","shares_owned_after":695840.0,"shares_owned_after_display":"695,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-01","scope":"insider"},{"id":2426982,"accession":"0001562180-24-001993","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-001993","line_url":"/filing/0001562180-24-001993#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8367.0,"shares_display":"8,367","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":12717.84,"total_display":"12,717.84","shares_owned_after":703009.0,"shares_owned_after_display":"703,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider"},{"id":2821065,"accession":"0001562180-24-000970","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-000970","line_url":"/filing/0001562180-24-000970#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24311.0,"shares_display":"24,311","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":40842.48,"total_display":"40,842.48","shares_owned_after":711376.0,"shares_owned_after_display":"711,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-02","scope":"insider"},{"id":3083110,"accession":"0001562180-24-003948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-003948","line_url":"/filing/0001562180-24-003948#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":31050.0,"total_display":"31,050.00","shares_owned_after":668840.0,"shares_owned_after_display":"668,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-25","filed_date":"2024-05-09","scope":"insider"},{"id":8007093,"accession":"0001562180-23-004254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-004254","line_url":"/filing/0001562180-23-004254#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63567.0,"shares_display":"63,567","price_per_share":1.068,"price_display":"1.07","price_state":"stated","total_value":67889.556,"total_display":"67,889.56","shares_owned_after":530487.0,"shares_owned_after_display":"530,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":8747737,"accession":"0001562180-23-002199","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-23-002199","line_url":"/filing/0001562180-23-002199#line-3","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6613.0,"shares_display":"6,613","price_per_share":0.8775,"price_display":"0.88","price_state":"stated","total_value":5802.9075,"total_display":"5,802.91","shares_owned_after":601564.0,"shares_owned_after_display":"601,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider"},{"id":8747736,"accession":"0001562180-23-002199","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-002199","line_url":"/filing/0001562180-23-002199#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6400.0,"shares_display":"6,400","price_per_share":0.8775,"price_display":"0.88","price_state":"stated","total_value":5616.0,"total_display":"5,616.00","shares_owned_after":595164.0,"shares_owned_after_display":"595,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider"},{"id":8747732,"accession":"0001562180-23-002199","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-002199","line_url":"/filing/0001562180-23-002199#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1110.0,"shares_display":"1,110","price_per_share":0.8775,"price_display":"0.88","price_state":"stated","total_value":974.025,"total_display":"974.02","shares_owned_after":594054.0,"shares_owned_after_display":"594,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider"},{"id":8128728,"accession":"0001562180-23-002040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-002040","line_url":"/filing/0001562180-23-002040#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7539.0,"shares_display":"7,539","price_per_share":0.8132,"price_display":"0.81","price_state":"stated","total_value":6130.7148,"total_display":"6,130.71","shares_owned_after":608177.0,"shares_owned_after_display":"608,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-01","scope":"insider"},{"id":6937413,"accession":"0001562180-22-006402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-006402","line_url":"/filing/0001562180-22-006402#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1147.0,"shares_display":"1,147","price_per_share":0.3625,"price_display":"0.36","price_state":"stated","total_value":415.7875,"total_display":"415.79","shares_owned_after":418016.0,"shares_owned_after_display":"418,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-31","filed_date":"2022-09-01","scope":"insider"},{"id":6495341,"accession":"0001562180-22-002165","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-22-002165","line_url":"/filing/0001562180-22-002165#line-4","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6556.0,"shares_display":"6,556","price_per_share":2.1707,"price_display":"2.17","price_state":"stated","total_value":14231.1092,"total_display":"14,231.11","shares_owned_after":217263.0,"shares_owned_after_display":"217,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider"},{"id":6495338,"accession":"0001562180-22-002165","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-22-002165","line_url":"/filing/0001562180-22-002165#line-3","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":2.1707,"price_display":"2.17","price_state":"stated","total_value":2387.77,"total_display":"2,387.77","shares_owned_after":217663.0,"shares_owned_after_display":"217,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider"},{"id":6495337,"accession":"0001562180-22-002165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-002165","line_url":"/filing/0001562180-22-002165#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7400.0,"shares_display":"7,400","price_per_share":2.1548,"price_display":"2.15","price_state":"stated","total_value":15945.52,"total_display":"15,945.52","shares_owned_after":163819.0,"shares_owned_after_display":"163,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"},{"id":5496116,"accession":"0001562180-21-005744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-005744","line_url":"/filing/0001562180-21-005744#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1042.0,"shares_display":"1,042","price_per_share":2.83,"price_display":"2.83","price_state":"stated","total_value":2948.86,"total_display":"2,948.86","shares_owned_after":171219.0,"shares_owned_after_display":"171,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-31","filed_date":"2021-09-02","scope":"insider"},{"id":5258849,"accession":"0001562180-21-002539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-002539","line_url":"/filing/0001562180-21-002539#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1081.0,"shares_display":"1,081","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":3675.4,"total_display":"3,675.40","shares_owned_after":170761.0,"shares_owned_after_display":"170,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-01","scope":"insider"},{"id":5324780,"accession":"0001562180-21-001781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-001781","line_url":"/filing/0001562180-21-001781#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7558.0,"shares_display":"7,558","price_per_share":3.3961,"price_display":"3.40","price_state":"stated","total_value":25667.7238,"total_display":"25,667.72","shares_owned_after":161442.0,"shares_owned_after_display":"161,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":8747959,"accession":"0001562180-19-005640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-005640","line_url":"/filing/0001562180-19-005640#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP, Chief Medical Officer)","officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27000.0,"shares_display":"27,000","price_per_share":3.58,"price_display":"3.58","price_state":"stated","total_value":96660.0,"total_display":"96,660.00","shares_owned_after":37000.0,"shares_owned_after_display":"37,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-22","scope":"insider"},{"id":4143877,"accession":"0001171843-17-007734","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001171843-17-007734","line_url":"/filing/0001171843-17-007734#line-6","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"PROTEON THERAPEUTICS INC","issuer_ticker":"PRTO","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":"0001619834","owner_name":"Burke Steven Keith","owner_url":"/insider/0001619834","role":"Officer (SVP and Chief Medical Officer)","officer_title":"SVP and Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":1.88,"price_display":"1.88","price_state":"stated","total_value":22560.0,"total_display":"22,560.00","shares_owned_after":117535.0,"shares_owned_after_display":"117,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-15","filed_date":"2017-12-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001517022","name":"Akebia Therapeutics, Inc.","url":"/issuer/0001517022","role":"Officer (SVP, Chief Medical Officer)","n_filings":16,"first_seen":"2019-11-22","last_seen":"2026-02-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001359931","name":"PROTEON THERAPEUTICS INC","url":"/issuer/0001359931","role":"Officer (SVP and Chief Medical Officer)","n_filings":1,"first_seen":"2017-12-18","last_seen":"2017-12-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001619834","retrieved_at":"2026-08-21T11:24:39+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}